Cancer stem cells: controversies in multiple myeloma

Overview of attention for article published in Journal of Molecular Medicine, September 2009

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (73rd percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

patent: 3 patents

Citations

dimensions_citation: 30 Dimensions

Readers on

mendeley: 47 Mendeley
connotea: 1 Connotea

Summary Patents Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

Neuregulin antagonists and use thereof in treating cancer

Grant US-9556249-B2

United States of America

NEUREGULIN ANTIBODIES AND USES THEREOF

Application WO-2013025853-A1

World Intellectual Property Organisation (WIPO)

NEUREGULIN ANTAGONISTS AND USE THEREOF IN TREATING CANCER

Application WO-2011103242-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.